Gregor Krings, Ph.D.
Affiliations: | 2008 | Medical University of South Carolina, Charleston, SC, United States |
Area:
Molecular Biology, Cell Biology, Microbiology BiologyGoogle:
"Gregor Krings"Parents
Sign in to add mentor| Deepak Bastia | grad student | 2008 | MUSC | |
| (Site-specific DNA replication fork arrest within the ribosomal DNA intergenic spacer regions of Schizosaccharomyces pombe.) | ||||
| Barbara Panning | post-doc | (Cell Biology Tree) | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kang T, Yau C, Wong CK, et al. (2020) A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population. Breast Cancer Research : Bcr. 22: 81 |
| Mukhtar RA, Krings G, Chen YY, et al. (2020) Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival. Breast Cancer Research and Treatment |
| Beca F, Krings G, Chen YY, et al. (2020) Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc |
| Venters SJ, Wolf DM, Brown-Swigart L, et al. (2020) Abstract P6-10-02: Assessing biomarkers to inform treatment de-escalation: Mid-treatment biopsy cellularity predicts pCR in the I-SPY 2 Trial Cancer Research. 80 |
| Benz CC, Kang T, Yau C, et al. (2020) Abstract P3-08-20: The normal breastActivetranscriptome associated with future breast cancer risk is driven by a dysregulated adipocyte microenvironment Cancer Research |
| Osdoit M, Yau C, Symmans WF, et al. (2020) Abstract P3-08-16: The impact of residual ductal carcinoma in situ on breast cancer recurrence in the neoadjuvant I-SPY2 TRIAL Cancer Research. 80 |
| Yau C, DeMichele A, Symmans WF, et al. (2020) Abstract P2-20-02: Site of recurrence after neoadjuvant therapy: Clues to biology and impact on endpoints Cancer Research. 80 |
| Harrison BT, Fowler E, Krings G, et al. (2019) Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast. The American Journal of Surgical Pathology |
| Kang T, Yau C, Benz S, et al. (2019) Abstract 3314: Normal breast tissue at risk for cancer development: A breast cancer initiating role for mammary adipocytes Cancer Research. 79: 3314-3314 |
| Shamir ER, Chen YY, Chu T, et al. (2018) Pleomorphic and Florid Lobular Carcinoma in Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center. The American Journal of Surgical Pathology |